Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$16.86 – $24.69
91% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.57B | $3.18B | $3.00B | $3.02B | $2.98B | $3.70B | $3.68B | $5.49B |
| Cost of revenue | $0 | $0 | $0 | $1.02B | $0 | −$976.7M | $0 | $1.15B |
| Gross profit | $2.57B | $3.18B | $3.00B | $3.02B | $2.98B | $4.68B | $3.68B | $5.49B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 126.4% | 100.0% | 100.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $183.5M | $43.7M | −$224.2M | $2.40B | $2.91B | $719.5M | $685.4M | $749.0M |
| EBITDA | $193.9M | $134.5M | −$182.1M | $293.7M | $375.3M | $769.0M | $799.2M | $884.5M |
| Net income | $112.6M | $48.9M | −$293.7M | $189.5M | $253.9M | $712.0M | $627.2M | $617.5M |
| Net margin | 4.4% | 1.5% | -9.8% | 6.3% | 8.5% | 19.2% | 17.1% | 11.2% |
| EPS (diluted) | 0.31 | 0.13 | -0.67 | 0.54 | 0.73 | 2.01 | 1.40 | 1.79 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $5.3B | $1.71 | $1.61–$1.81 | 1 |
| 2027 | $5.4B | $1.97 | $1.85–$2.09 | 1 |
| 2028 | $5.9B | $2.45 | $2.31–$2.61 | 1 |
| 2029 | $10.6B | $2.25 | $2.12–$2.39 | 1 |
Forward consensus · source: Financial Modeling Prep
HISCOX LTD ORD NEW
No one on the platform currently holds HCXLF.
No tracked institution reports a position in HCXLF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-24 | $0.3590 | 2026-06-08 |
| 2025-08-15 | $0.1440 | 2025-09-23 |
| 2025-04-25 | $0.2990 | 2025-06-09 |
| 2024-08-16 | $0.1320 | 2024-09-24 |
| 2024-05-02 | $0.2500 | 2024-06-12 |
| 2023-08-17 | $0.1250 | 2023-09-26 |
| Execution date | Ratio |
|---|---|
| 2025-08-15 | 121.186916-for-120.186916 |
| 2025-04-25 | 56.6455-for-55.6455 |
| 2024-08-16 | 118.81095-for-117.81095 |
| 2024-05-02 | 59.94039-for-58.94039 |
No one on the platform has traded HCXLF yet.
| $5.3B |
| — |
| IVTJFInvestec Group | $6.96 | -18.98% | $5.9B | — |
| IVTJYInvestec Group | $16.58 | -4.36% | $5.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-08-17 | 97.75675-for-96.75675 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 13.9× earnings vs its 9.4× historical median P/E.
Fair value ≈ $16.24 · price $24.02 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.